Evidence map›Paper›PMID 30302587›Full record

ArticleParasitology research2018

Cercarial dermatitis: a systematic follow-up study of human cases with implications for diagnostics.

Tomáš Macháček, Libuše Turjanicová, Jana Bulantová, Jiří Hrdý, Petr Horák, Libor Mikeš

Abstract read
PubMed Publisher
In one paragraph

Article in Parasitology research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. The avian schistosomeFood and waterborne parasitology · 2025
    Article
  4. TRPV1+ neurons promote cutaneous immunity against Schistosoma mansoni.Journal of immunology (Baltimore, Md. : 1950) · 2025
    Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Other Schistosomatoidea and Diplostomoidea.Advances in experimental medicine and biology · 2024
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. First Record ofPathogens (Basel, Switzerland) · 2021
    Article
  17. Article
  18. Article
  19. Article
  20. Isoforms of Cathepsin B1 in Neurotropic Schistosomula ofFrontiers in cellular and infection microbiology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Tomáš MacháčekDepartment of Parasitology, Faculty of Science, Charles University, Viničná 7, 12844, Prague 2, Czech Republic.
Libuše TurjanicováDepartment of Parasitology, Faculty of Science, Charles University, Viničná 7, 12844, Prague 2, Czech Republic.
Jana BulantováDepartment of Parasitology, Faculty of Science, Charles University, Viničná 7, 12844, Prague 2, Czech Republic.
Jiří HrdýInstitute of Immunology and Microbiology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Studničkova 7, 12800, Prague 2, Czech Republic.
Petr HorákDepartment of Parasitology, Faculty of Science, Charles University, Viničná 7, 12844, Prague 2, Czech Republic.
Libor MikešDepartment of Parasitology, Faculty of Science, Charles University, Viničná 7, 12844, Prague 2, Czech Republic. mikes@natur.cuni.cz.ORCID http://orcid.org/0000-0002-2440-6641
Charles University · CZ

Funding

European Regional Development Fund CZ.02.1.01/0.0/0.0/16_019/0000759Grantová Agentura České Republiky 13-29577SGrantová Agentura České Republiky 18-11140SUniverzita Karlova v Praze PROGRES Q43Univerzita Karlova v Praze SVV 244-260432/2017Univerzita Karlova v Praze UNCE 204017
6 · The paper itself

Abstract

Cercarial dermatitis (CD) is an allergic skin disease that rises in consequence of infection by invasive stages (cercariae) of trematodes of the family Schistosomatidae. CD has been considered a re-emerging disease, human cases have been reported from all continents, and tourism-threatening outbreaks occur even in frequented recreational areas. Although the symptoms of CD are generally known, the data on immune response in human patients are sporadic and incomprehensive. In the present study, we attempted to correlate the symptoms, personal history, and time course of CD in human patients with differential cell counts, dynamics of selected cytokines, and dynamics and quality of antibody response. By a systematic follow-up, we obtained a uniquely complex dataset from ten persons accidentally and concurrently infected by the same parasite species in the same locality. The onset of CD was significantly faster, and the symptoms were heavier in participants with a history of CD if compared to naive ones, who, however, also developed some of the symptoms. The repeatedly infected persons had elevated proportion of eosinophils 1 week post exposure (p.e.) and a stronger specific IgG but not IgM response, whereas specific IgE response was not observed. Increased serum levels of IL-4 occurred 1 and 3 week(s) p.e. in all participants. There was high variability in individual immunoblot patterns of IgG response, and no antigen with a universal diagnostic potential was confirmed. The presented analyses suggested that a complex approach can improve the accuracy of the diagnosis of CD, but component data should be interpreted carefully.

Indexed as

AdultAnimalsAntibodies, ProtozoanCzech RepublicDermatitisDisease OutbreaksFemaleFollow-Up StudiesHumansImmunoglobulin EImmunoglobulin GImmunoglobulin MInterleukin-4MaleMiddle AgedPondsAntibodies, ProtozoanIL4 protein, humanImmunoglobulin EImmunoglobulin GImmunoglobulin MInterleukin-4AllergyDiagnosisImmunitySchistosomeSkinTrichobilharzia

Identifiers

PMID30302587
OpenAlexW2897089047

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.